[Form 4] PROCEPT BioRobotics Corporation Insider Trading Activity

Rhea-AI Filing Summary

Nouri Alaleh, EVP and Chief Legal Officer of PROCEPT BioRobotics (PRCT), exercised stock options and acquired 11,000 shares on 08/14/2025. The exercise was a cash exercise at an exercise price of $4.52 per share for options that are fully vested and exercisable. After the transaction the reporting person beneficially owns 72,473 shares of common stock directly and holds derivative interests corresponding to 11,000 underlying shares, with 54,452 derivative securities beneficially owned following the transaction. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.

Positive

• Insider purchase: Reporting person executed a cash exercise to acquire 11,000 shares, increasing direct ownership to 72,473 shares.
• Options fully vested: The exercised options are fully vested and exercisable, indicating no remaining vesting condition for this tranche.

Negative

• None.

Insights

Financial Analyst

TL;DR: Insider exercised fully vested options and bought 11,000 PRCT shares at $4.52, increasing direct ownership to 72,473 shares.

The reporting person executed a cash exercise of 11,000 stock options at $4.52 per share on 08/14/2025. This is a direct purchase funded by the insider rather than a secondary sale, which can signal confidence in the issuer's outlook or a routine exercise of vested compensation. The transaction increases the insider's direct stake to 72,473 shares and leaves 54,452 derivative securities outstanding after the exercise. For investors, this is a clear data point on insider alignment but contains no forward guidance or company performance metrics.

Corporate Governance Expert

TL;DR: Routine, fully vested option exercise reported on Form 4; properly documented and signed by attorney-in-fact.

The filing documents a standard Section 16 disclosure: a vested option exercise by an executive who is an officer and director. The Form 4 shows the required details including transaction date, price, and post-transaction beneficial ownership. The signature was provided by an attorney-in-fact, which is permissible under Form 4 rules. This appears procedural rather than indicative of a governance event or policy change.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nouri Alaleh

(Last) (First) (Middle)

C/O PROCEPT BIOROBOTICS CORPORATION

150 BAYTECH DRIVE

(Street)

SAN JOSE CA 95134

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PROCEPT BioRobotics Corp [ PRCT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, CLO, CORP. SEC.

3. Date of Earliest Transaction (Month/Day/Year)
08/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/14/2025		M		11,000	A	$4.52	72,473	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$4.52	08/14/2025		M(1)			11,000	(2)	09/27/2028	Common Stock	11,000	$0	54,452	D

Explanation of Responses:

1. Transaction is a cash exercise by the reporting person.

2. The option is fully vested and exercisable.

Remarks:

	/s/ Jonathan Stone, Attorney-in-Fact for Alaleh Nouri	08/14/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Nouri Alaleh report for PRCT on 08/14/2025?

The report shows a cash exercise of 11,000 stock options at an exercise price of $4.52 per share on 08/14/2025.

How many PRCT shares does the reporting person own after the transaction?

After the transaction the reporting person beneficially owns 72,473 shares of common stock directly.

Were the options exercised by the reporting person vested?

Yes. The Form 4 states the option was fully vested and exercisable at the time of exercise.

What was the exercise price of the options and how much did the reporting person pay per share?

The exercise price disclosed on the Form 4 is $4.52 per share.

Does the filing indicate whether the transaction was part of a Rule 10b5-1 plan?

The Form 4 does not indicate that this transaction was made pursuant to a Rule 10b5-1 trading plan.

Who signed the Form 4 and in what capacity?

The Form 4 was signed by Jonathan Stone, Attorney-in-Fact for Alaleh Nouri on 08/14/2025.